# 



## 

## 

## 



## 

## 

## 

|Trustees<br>Annual<br>Report|Trustees<br>Annual<br>Report||
|---|---|---|
|Statement<br>ofTrustees'|Responsibilities|22|
|Independent<br>Auditors'|Report|23-24|
|Statement<br>of Financial|Activities|25|
|Balance Sheet||26|
|Cash Flow Statement||27|
|Notes to the accounts||29|





## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

## 



## 


## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

|||||||as restated|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total Funds|
||||Funds|Funds|Funds|Year to|
||||Year to|Year to|Year to|31 Dec 20|
||||31 Dec 21|31 Dec 21|31 Dec 21||
|||Note|P||||
|INCOME AND ENDOWMENTS|FROM||||||
|Donations<br>and legacies||||||65,157|
|Charitable<br>activities|||||||
|Education|||135,429||135,429|52,764|
|Provision<br>of publication|||132,643||132,643|128,343|
|Annual<br>General<br>Meeting|||218,833||218,833|61,059|
|Other trading<br>activities|||291,444||291,444|274,859|
|Investment<br>income|||94||94|904|
|TOTAL INCOME|||778443||778443|583,086|
|EXPENDITURE ON|||||||
|Raising funds|||||||
|Charitable<br>activities:|||||||
|Bursaries|||||||
|Education|||115,981||115,981|90,805|
|Provision<br>of publications|||59,526||59,246|59,248|
|Annual<br>General<br>Meeting|||268,092||268,092|189,288|
|Governance<br>costs|||180,183||180,183|164,181|
|BDRF net||||||155,417|
|TOTAL EXPENDITURE|||623502||623502|655,939|
|NET INCOME/(EXPENDITURE)|||154,941||154941|(72,853)|
|Subsidiary<br>demerger||14||||273,833|
|Net Movement<br>in funds|||154,941||154,941|(346,686)|
|RECONCILIATION<br>OF FUNDS|||||||
|Total funds brought<br>forward|||1,227,745|8,532|1,236,277|1,582,963|
|Total funds carried forward|||1 382,686|8,532|1,391218|1,236,277|





## 

## 

## 




## 

## 

||||||as|
|---|---|---|---|---|---|
||||||restated|
|||||2021|2020|
||||||P.|
|Cash flows from operating||||||
|activities||||||
|Cash generated<br>from operations||||46,643|(75,431)|
|Interest Paid||||||
|Net cash <br>operating|provided<br>activities|by (used|in)|46,643|(75,431)|
|Net cash|provided|by (used|in)|||
|Investing|activities|||||
|Purchase|of fixed assets|||(59,784)|(449)|
|Change|in cash and cash|||||
|equivalents<br>in the||reporting||(13,141)|(75,880)|
|period||||||
|Cash and cash equivalents|||at|||
|The beginning<br>of the reporting||||982,949|1,058,829|
|period||||||
|||||969,808|982,949|





## 

## 

|||||||as|
|---|---|---|---|---|---|---|
|||||||restated|
||||||2021|2020|
|Net income for the|reporting|||period (as|||
|per the statement|of|financial||activities)|154,941|22,567|
|Adjustments<br>for:|||||||
|Depreciation<br>charges|||||7,649|3,509|
|Loss on asset disposal|||||2,520||
|Current assets less|current||liabilities:||||
|Decrease<br>/ (increase)||in debtors|||(165,815)|(104,234)|
|Increase<br>/ (decrease)||in creditors|||47,348|2,727|
||||||46,643|(75,431)|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

|Computer|equipment|25% reducing|balance|
|---|---|---|---|
|Office equipment||15%reducing|balance|
|Exhibition|stand|15%reducing|balance|
|Chain of|Office & Medal Dies|20% straight|line|



## 

## 

## 

## 



## 

## 

## 

## 

## 

|ONATION|S<br>AND LEGACIES|||||
|---|---|---|---|---|---|
|||||2021|2020|
|Donations|(from trusts, events, private companies,|individuals,|etc)||65,157|
||||||65,157|
|THER TRADING ACTIVITIES||||||
|||||2021|2020|
|Subscriptions||||291,444|274,859|
|||||291 444|274,859|



## 

## 

|2021|2020|
|---|---|
|94|904|
|94|904|



## 

|COME FROM|CHARITA|BLE ACT|IVITIES|||||
|---|---|---|---|---|---|---|---|
|||||||2021|2020|
||||Activity||||F|
|Pelvic Floor Society<br>Coloproctology<br>motorway<br>Dukes' Club||course|Education<br>Education<br>Education|||42,023<br>58,000|5,500<br>650<br>29,189|
|Other meetings<br>lleal Pouch|||Education<br>Education|||35,406|2,425<br>15,000|
|Publication<br>Income<br>Annual<br>General<br>Meeting|||Provision<br>of Colorectal journal<br>Annual<br>General<br>Meeting|||132,643<br>218,833|128,343<br>61,059|
|||||||486 905|242,166|





||||||VJ0C<br>LL||O<br>N<br>IO<br>N<br>O<br>Ql|CLJ|CO<br>CO<br>N<br>Ol<br>CO|Nr&COC<br>CIJ N<br>LA ll N <br>CO COCO NIO<br>IO<br>I<br>O Ol<br>LA <br>LA|Nr&COC<br>CIJ N<br>LA ll N <br>CO COCO NIO<br>IO<br>I<br>O Ol<br>LA <br>LA|Nr&COC<br>CIJ N<br>LA ll N <br>CO COCO NIO<br>IO<br>I<br>O Ol<br>LA <br>LA|Nr&COC<br>CIJ N<br>LA ll N <br>CO COCO NIO<br>IO<br>I<br>O Ol<br>LA <br>LA|Nr&COC<br>CIJ N<br>LA ll N <br>CO COCO NIO<br>IO<br>I<br>O Ol<br>LA <br>LA|OJN<br> ~ C)<br>N<br> C,- CO<br>CI)|OJN<br> ~ C)<br>N<br> C,- CO<br>CI)|W<br>lp<br>CJ)|CIJ<br>LA<br>r||Cd Ol~<br>IO OJg<br>C ro<br>Wrr|Cd Ol~<br>IO OJg<br>C ro<br>Wrr|LA <br>CO <br>I<br>I|LA <br>CO <br>I<br>I|W<br> CO<br>l|N VJ <br>ION<br>N<br>CIJ <br>IA<br>CO<br>I|N VJ <br>ION<br>N<br>CIJ <br>IA<br>CO<br>I|C9<br>Cd<br> N<br>r|CO<br>CI<br>lA<br>Ol|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||0<br>I—||CI||||||||||||||||||||||||
||||||ID<br>'0<br>C<br>LJ.||rOJN<br>N<br>Dl<br>CD<br>IO|||CD N <br>IA ID <br>COJI <br>~Q'<br>LA <br>l-||JI<br>ID IQ' Cl<br> IA N 0)<br> LDLAr8<br> N<br>Cll<br>JI<br>LA<br>CIJ<br>LA|||||CO IO<br>Ra<br>Dlr|||g IDO)<br>CD CQ~<br>Chr<br>LA"<br>CO r||IAl|||IA ID <br>CJ CJ <br>r5 <br>IQ'<br>LA<br>l-r||DI<br> Ol<br> CIJ<br>CO<br>N|g<br>S|CI<br>IA<br>N||
||||||0I-||||||||||||||||||||||||||
||||||Qlo<br>IOCI||VJ <br>Vl0o|GJ||~|I|I|I|I|I|I|I|I||CO CIJ <br>Dlr<br>CO l|r<br>LA|LA<br>l|||LA/<br>~Q'<br>LA<br>r r||Cb<br>CO<br> N|CD<br>CO|||
||||||QJ|||||||||||||||||||||||l|||
||||||0Q||||||||||||||||||||||||||
||||||IQ||0l|OJ|Cd<br>DI0||||||||||N<br>DI<br>Cl|~<br>I|I||I|I|I|~|I||N<br>CJI<br>C)||
||||||CC||Qle<br>E||Cd||||||||||||||||||||||
||||||»0<br>C0<br>VJ||" <br>C0<br>Id0|OJ||||I|IO<br>N<br>IA<br>Ol<br>IA|~||||||~<br>I|I||I|~|I|I|I||ID<br>Ol<br>IA||
|OZ<br>IL:|||||0<br>CL||Zl<br>CL<br>C <br>0|OJ||CD <br>IA <br>ID|Nh.<br> ID LA<br> N ID||I|g <br>v|Cl<br>IO|I|CO <br>Ch <br>N|IO<br> IO<br> IO|l<br>CO<br>Dl|~<br>I|I||I|I||I|I||l<br>CO<br>Dl|0<br>Vl000<br>Ql|
|OZ|||||||Ido|||~Q' <br>r|IA|Cd||h|LA<br>I||DI|r|IA<br>ll||||||||||LA<br>Il|CL|
||||||||LLJ||||||||||||||||||||||||
|Z||||||||||||||||||||||||||||||Ql|
|||||||||||||||||||||||||||||||Ql|
|I-<br>K|||||||VJ<br>eI<br>Id|CLJ|I|I|I|I|I|I|I|I|I|I||I<br>I|I||I|I|I|I|I|||VJ|
|CCII-|||||||VJ|||||||||||||||||||||||Ql|
||||||||CCL|||||||||||||||||||||||Ql|
|IX6<br>0<br>00|O|||||Vlm<br>Vl<br>c<br>VJ LL<br>Id<br>CL:||CLJ|I|I|I|I|~|I|I|I|I|I||I<br>I|I||I|~|I|I|I|||VJ<br>QJ<br>Ido<br>0<br>'0|
|||||||||||||||||||||||||||||||Ql|
|Q~ LU<br>o~<br>p I-<br>CL."cQ;<br>o~<br>Qo~<br>p<br>CCI<br>ZO<br>Og<br>I-g<br>pW<br>0<br>Co<br>u) +<br>~ CL<br>LU0<br>+O<br>I-~|DzI-Z0O<br>MI-ZD000<br>ZI-0I-<br>M<br>I-0Z|CLLO<br>CLL<br>CL:<br>LLI<br>LLIO<br>LLIO<br>l<br>O<br>LLIOZ<br>LU<br>CL:<br>cC<br>LU|LU<br>ILL<br>I-<br>CC<br>LU cC<br>D~o<br>I-02<br>by<br>25<br>LUZ<br>~-u)<br>X V)<br>LLI<br>LU~—<br>&o&<br>I ZP<br>pzO<br>I<br>LL cC||||||C<br>e<br>0 <br>5 <br>CC|2<br> O<br>= <br>Ql <br> ~<br> I-|vl <br>QJ <br> e <br> E <br>dl <br>0|e<br>Ql<br>g<br>VI<br>Ql<br>O<br>Id<br>e<br>Ql<br>gp&M»<br> o Q, IQ o &,<br> O.O<br>CL VJ O 0 e<br> 0 —Co e<br>—E<br> O<br>CL—CC<br>5 —CLVJ»<br> )<br>Vl '0& e p e<br>Q-<br>dO~)re<br>e 0 0 0 0<br> CL Cn<br>CJJ<br>CCJ Oa O|||||||IQ0<br>CJJ|0o<br>CA<br>e<br>'d<br>Qo-~<br>C c<br>I- e<br>Id<br>Oe<br>CC E<br>Pl c<br>CL c e<br>Id e<br>CA X W|PJ<br>Ql<br>0 o<br>c 2<br>0 e<br>g<br>Vl<br>I- o<br>C<br>Id<br>VJ<br>E.E<br>p E<br>8|||ItI <br>IE|ee<br>IQC<br>Id .<br>VJ<br>Ql0<br>VJ<br>Id<br>CL VJ<br> C~ 8<br>e<br> & ~e5|||Id<br>CJJ|CI<br>Oz<br>CA<br>O<br>CC<br>0<br>CA<br>LLJ<br>CC<br>I-0I-|p<br>Cd<br>o<br>Ql<br>Ql<br>Ql<br>Xl<br>Ql<br>IQ<br>Vl<br>Vl<br>8<br>0<br>CL<br>CL<br>(fJ|






## 

## 

|NOTE|S TO THE ACCOUNTS CONTINUED|S TO THE ACCOUNTS CONTINUED||||
|---|---|---|---|---|---|
|YEAR|ENDED 31 DECEMBER 2021|||||
|8.|GRANTS PAYABLE TO INSTITUTIONS|||||
|||||2021|2020|
||||||P|
||Bowel Research<br>UK|||15,000|30,249|
|9.|NET INCOMING/<br>(OUTGOING) RESOURCES|||||
||Net resources are stated after charging/(crediting)|||2021|2020|
||Auditors<br>remuneration|||11,625|12,752|
||Auditors<br>remuneration|for non-audit|work|2,500|2,500|
||Depreciation<br>—owned|assets||7,649|3,509|
||Loss on asset disposal|||2,520||



## 

|There wer<br>ended 31|e no trustees'<br>remuneration<br>or other benefits <br> December 2020.|for the year ended 31 December 2021 nor t|he year|
|---|---|---|---|
|||2021|2020|
|Trustees'|expenses|2,340|1,669|



## 

|STAFF COSTS||||||||
|---|---|---|---|---|---|---|---|
|||||||2021|2020|
|Wages and salaries<br>Social security costs<br>Pension costs||||||73,329<br>3,840<br>11915|79,91<br>I<br>5,127<br>12,273|
|||||||89084|97,311|
|The average<br>monthly|number|of employees|during||the year was as follows:|||
|||||||2021|2020|
|Fundraising<br>and administration||||||||
|The key management|for the|charities comprise||of|the Trustees, CEO, and|co-ordinators.||





## 

## 

|NTANGIBLE FIXEDASSETS||
|---|---|
||Software|
||&Website|
|COST||
|At 1 Jan 2021|12,600|
|Addition<br>Disposal|59,784<br>~12,800|
|At 31 Dec 2021|59,784|
|DEPRECIATION||
|At1 Jan 2021|7,560|
|Charge for the year<br>Disposal|7,502<br>~10,080|
|At 31 Dec 2021|4 882|
|NET BOOK VALUE||
|AT 31 DEC 2021|54 802|
|AT 31 DEC 2020|5,040|



## 

|TANGIBLE FIXED ASSE|TS||||
|---|---|---|---|---|
||Office|Computer|Office &||
||Equipment|equipment|medal dies|Total|
|COST|||||
|At 31 Dec 2021|2329|889|4,064|7,282|
|DEPRECIATION|||||
|At1 Jan 2021|2,070|456|3,116|5,642|
|Charge for the year|37|108||147|
|At 31 Dec 2021|2,107|564|3 116|5789|
|NET BOOK VALUE|||||
|AT 31 DEC 2021|222|325|948|1 493|
|AT 31 DEC 2020|259|433|948|1,640|
|(b) CHARITY|||||
|NET BOOK VALUE|||||
|AT 31 DEC 2021|220|325|948|1 493|
|AT 31 DEC 2020|259|433|948|1,640|





## 

## 

## 

## 

|||2021|2020|
|---|---|---|---|
||||P|
|AGM 2024 8 <br>AGM 2023 &|2025 Prepaid expenses<br>2024 Prepaid expenses|53,966<br>21„177|15,831<br>15,831|
|AGM 2022 Prepaid expenses||231,402|33,561|
|AGM 2021 Prepaid expenses|||73,179|
|Trade debtors||24,776|6,583|
|Prepayments|and accrued income|41,464|82,116|
|Other debtors||132,643|128,343|
|||505428|339,613|



## 

||2021|2020|
|---|---|---|
|Deferred income|25,512|31,898|
|Accruals|26,358|43,404|
|Trade creditors|73,847|7,189|
|Other taxation|15,075|10,953|
||140792|93,444|





## 

## 

## 

## 

## 

|RESTRICTE|D FUNDS||||||
|---|---|---|---|---|---|---|
|||Balance at|Incoming|Resources|Transfers|Balance at|
|||1 Jan 2021|resources|expended|between|31 Dec 2021|
||||||funds||
|||R||P|||
|Laparoscopic|Colorectal Surgery|7,532||||7,532|
|6ursaries|||||||
|Scottish Chapter||1 000||||1,000|
|||8532||||8532|





## 

## 

## 

|NALYS|IS OF NET ASSETS BETWE|EN FUNDS||||
|---|---|---|---|---|---|
|||Restricted|General|2021|2020|
|||Funds|Funds|||
|Fixed assets|||56,295|56,295|6,680|
|Current|assets/liabilities|8,532|1,326,391|1,334,923|1,229,597|
|||8,532|1 382,686|1 391,218|1,236,277|



## 

## 

## 

|The<br>following<br>assumptions<br>iabilities:|were<br>used<br>to as|sess<br>t|he past|service<br>funding<br>p|osition<br>and<br>future|service|
|---|---|---|---|---|---|---|
||||||Projected|Unit|
||||||Technical|Future|
|Valuation<br>method|||||Provisions|Service|
|Investment<br>return —pre-retirement<br>Investment<br>return —post-retirement|||||2.45%p.a.<br>0.35%p.a.|3.62%<br>2.37%|
|Price Inflation<br>(RPI)|Full unadjusted|market|implied|RPI Curve|||
|Price Inflation<br>(CPI)|Full Curve derived as||RPI Curve less 1%p.a,||||
||before 2030 and|no deduction||thereafter.|||
|General salary increase|Full Curve derived as||RPI Curve less 1%p.a||||





## 

## 

## 

## 

## 



## 

## 

## 

|YEAR ENDED|31|DECE|MBER 2021|||
|---|---|---|---|---|---|
||||||as restated|
|||||Year to|Year to|
|||||31 Dec 21|31 Dec 20|
|INCOME||||||
|Donations|||||65,157|
|AGM Income||||218,833|61,059|
|Subscriptions||||291,444|274,859|
|Publication<br>income||||132,643|128,343|
|Pelvic Floor Society||||42,023|5,500|
|Coloproctology|motorway||course||650|
|Dukes' Club||||58,000|29,189|
|Other meetings/income||||35,406|2,425|
|Ileal Pouch||||15,000|15,000|
|Bank interest<br>receivable||||94|904|
|Total Incoming||Resources||778,443|583,086|
|EXPENDITURE||||||
|Charitable<br>activities||||||
|Annual<br>meeting<br>Subscription<br>to|colorectal||disease|268,092<br>59,526|189,288<br>59,248|
|Surgical Specialty||Lead||7,134|5,027|
|Travel fellowship||||14,850|6,832|
|Bowel Research||UK||15,000|30,249|
|Pelvic Floor Society||||32,657|10,857|
|Coloproctology|motorway||course||6,232|
|Dukes' Club||||39,298|19,534|
|Chapter meetings||||1,000|1,543|
|Other meetings||||5,762|7,621|
|||||443,319|336,341|





## 

## 

|||as restated|as restated|
|---|---|---|---|
|||Yearto|Year to|
|||31 Dec 21|31Dec20|
|Support<br>&Governance||||
|Costs||||
|Auditors<br>remuneration||14,125|15,252|
|Professional<br>fees||15,706||
|Payroll<br>& VAT services||4,218|4,642|
|Travel and meeting|expenses|11376|10,975|
|||45 425|30,869|
|Management||||
|Wages and salaries||89084|97,113|
|Information<br>technology||||
|Computer<br>maintenance||3,621|6,357|
|Website expenses||1 558|2,829|
|||5179|9186|
|Administrative<br>services||||
|Administration<br>services||9,552|8,488|
|Postage and stationery||2,086|1,114|
|Telephone<br>and conference calls||3692|5,492|
|||15330|15,094|
|Finance costs||||
|Credit card charges||20|390|
|Bank charges||964|705|
|||984|1,085|
|Other costs||||
|Sundry costs||500|708|
|Subscriptions||2,495||
|Bad debts||2,532||
|Depreciation||7,649|3,509|
|Loss on asset disposal||2,520||
|Insurance||8485|6,617|
|||24 181|10834|
|TOTAL SUPPORT|COSTS|180,183|164,181|
|BDRF net|||155,417|
|TOTAL EXPENDITURE||623,502|655,939|
|NET INCOMING/|(OUTGOING)|||
|RESOURCES FOR THE YEAR||154941|72853|



